초록 ▼

The disclosed invention relates generally to sizing compositions, methods and apparatus for cleaning sized fiber glass strands, yarns and fabric without the use of high temperature thermal processes. More specifically, the invention relates to sizing compositions comprising a photocatalytically degr

The disclosed invention relates generally to sizing compositions, methods and apparatus for cleaning sized fiber glass strands, yarns and fabric without the use of high temperature thermal processes. More specifically, the invention relates to sizing compositions comprising a photocatalytically degradable organic material and a photocatalyst material, and methods and apparatus for cleaning photocatalytically degradable organic materials from the surface of the fiber glass strand.

대표청구항 ▼

The disclosed invention relates generally to sizing compositions, methods and apparatus for cleaning sized fiber glass strands, yarns and fabric without the use of high temperature thermal processes. More specifically, the invention relates to sizing compositions comprising a photocatalytically degr

The disclosed invention relates generally to sizing compositions, methods and apparatus for cleaning sized fiber glass strands, yarns and fabric without the use of high temperature thermal processes. More specifically, the invention relates to sizing compositions comprising a photocatalytically degradable organic material and a photocatalyst material, and methods and apparatus for cleaning photocatalytically degradable organic materials from the surface of the fiber glass strand. consisting of Ea-2 and Ea-4 domain peptides having the amino acid sequence of SEQ ID NOS:2 or 4 and E-domain fusion proteins having the amino acid sequence of SEQ ID NOS: 2 or 4. 6. The method of claim 5, wherein the E-domain peptide is an E-domain peptide of a rainbow trout. 7. The method of claim 6, wherein the trout E-domain peptide is selected from the group consisting of: Ea-2 domain peptide (SEQ ID NO: 2) and Ea-4 domain peptide (SEQ ID NO: 4). ing Regions of a variable region of FIG. 12, wherein the Complementarity Determining Region amino acid sequences of the peptide are at least 70% homologous to the Complementarity Determining Region amino acid sequences chosen from at least one of: amino acids 31-35 of SEQ ID NO. 87, amino acids 50-68 of SEQ ID NO. 87, amino acids 101-112 of SEQ ID NO. 87, amino acids 24-33 of SEQ ID NO. amino acids 49-55 of SEQ ID NO. 89, and amino acids 88-96 of SEQ ID NO.89. 19. A composition comprising at least one peptide of claims 16, 17, or 18 and a pharmaceutically acceptable carrier.